Guardian Pharmacy Services, Inc. (GRDN) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	1.5B	1.4B	1.2B	1.0B	908.9M
Cost of Revenue	1.1B	1.2B	984.0M	837.9M	723.0M
Gross Profit	316.6M	282.0M	244.4M	208.3M	185.9M
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	224.8M	193.1M	307.3M	167.4M	133.9M
General & Admin Expense	—	—	—	—	(3.4M)
Selling & Marketing Expense	—	—	—	—	137.3M
Other Expenses	—	—	—	—	—
Total Operating Expenses	224.8M	193.1M	307.3M	167.4M	133.9M
Cost and Expenses	1.4B	1.4B	1.3B	1.0B	856.9M
Operating Income (EBIT)	91.7M	88.9M	(62.9M)	40.9M	52.0M
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	631.0K	665.0K	3.3M	2.9M	1.9M
Net Interest Income	(631.0K)	(665.0K)	(3.3M)	(2.9M)	(1.9M)
Other Non-Op Income/Expense	4.1M	(15.5M)	(3.6M)	(3.2M)	(2.3M)
Non-Operating Income (excl Interest)	(4.7M)	14.8M	279.0K	367.0K	403.0K
EBT (Pre-Tax Income)	95.8M	73.4M	(66.5M)	37.7M	49.7M
Income Tax Expense	29.3M	24.5M	4.6M	—	—
Bottom Line
Net Income	65.9M	49.2M	(87.3M)	23.9M	35.4M
Earnings from Cont. Ops	66.5M	49.0M	(71.0M)	37.7M	49.7M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	65.9M	49.2M	(110.0M)	23.9M	35.4M
Per Share
Basic EPS	$1.05	$0.79	($1.77)	$0.39	$0.58
Diluted EPS	$1.03	$0.78	($1.77)	$0.39	$0.58
Revenue Per Share	$23.11	$23.22	$19.81	$17.19	$14.94
Shares
Basic Shares Outstanding	63.3M	62.4M	62.0M	60.8M	60.8M
Diluted Shares Outstanding	63.8M	63.3M	62.0M	60.8M	60.8M
Profitability Metrics
EBITDA	114.0M	96.4M	(43.4M)	58.8M	68.2M
D&A	17.6M	22.3M	19.8M	18.2M	16.6M
EBIT	96.4M	74.1M	(63.2M)	40.6M	51.6M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026